Liao Zhiming, Nie Hui, Wang Yutong, Luo Jingjing, Zhou Jianhua, Ou Chunlin
Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Teaching and Research Room of Biochemistry and Molecular Biology, Medical School of Hunan University of Traditional Chinese Medicine, Changsha, China.
Front Oncol. 2021 Feb 25;11:641343. doi: 10.3389/fonc.2021.641343. eCollection 2021.
Colorectal cancer (CRC) is one of the most common gastrointestinal cancers, with extremely high rates of morbidity and mortality. The main cause of death in CRC is distant metastasis; it affects patient prognosis and survival and is one of the key challenges in the treatment of CRC. Long non-coding RNAs (lncRNAs) are a group of non-coding RNA molecules with more than 200 nucleotides. Abnormal lncRNA expression is closely related to the occurrence and progression of several diseases, including cancer. Recent studies have shown that numerous lncRNAs play pivotal roles in the CRC metastasis, and reversing the expression of these lncRNAs through artificial means can reduce the malignant phenotype of metastatic CRC to some extent. This review summarizes the major mechanisms of lncRNAs in CRC metastasis and proposes lncRNAs as potential therapeutic targets for CRC and molecular markers for early diagnosis.
结直肠癌(CRC)是最常见的胃肠道癌症之一,发病率和死亡率极高。CRC的主要死因是远处转移;它影响患者的预后和生存,是CRC治疗中的关键挑战之一。长链非编码RNA(lncRNAs)是一组长度超过200个核苷酸的非编码RNA分子。lncRNA表达异常与包括癌症在内的多种疾病的发生和进展密切相关。最近的研究表明,许多lncRNAs在CRC转移中起关键作用,通过人工手段逆转这些lncRNAs的表达可以在一定程度上降低转移性CRC的恶性表型。本综述总结了lncRNAs在CRC转移中的主要机制,并提出lncRNAs作为CRC潜在的治疗靶点和早期诊断的分子标志物。